Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients

Hyperventilation is common in pulmonary arterial hypertension and may be related to autonomic imbalance. Patients underwent exercise testing and hyperoxic breathing before and after bisoprolol treatment. We found that neither beta blocker treatment nor hyperoxic breathing in patients reduced hyperve...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Eva L., van Campen, Jasmijn S.J.A, Groepenhoff, Herman, de Man, Frances S., Noordegraaf, Anton Vonk, Bogaard, Harm J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671678/
https://www.ncbi.nlm.nih.gov/pubmed/34925761
http://dx.doi.org/10.1177/20458940211057890
_version_ 1784615188759052288
author Peters, Eva L.
van Campen, Jasmijn S.J.A
Groepenhoff, Herman
de Man, Frances S.
Noordegraaf, Anton Vonk
Bogaard, Harm J.
author_facet Peters, Eva L.
van Campen, Jasmijn S.J.A
Groepenhoff, Herman
de Man, Frances S.
Noordegraaf, Anton Vonk
Bogaard, Harm J.
author_sort Peters, Eva L.
collection PubMed
description Hyperventilation is common in pulmonary arterial hypertension and may be related to autonomic imbalance. Patients underwent exercise testing and hyperoxic breathing before and after bisoprolol treatment. We found that neither beta blocker treatment nor hyperoxic breathing in patients reduced hyperventilation at rest and during exercise, although it reduced heart rate.
format Online
Article
Text
id pubmed-8671678
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-86716782021-12-16 Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients Peters, Eva L. van Campen, Jasmijn S.J.A Groepenhoff, Herman de Man, Frances S. Noordegraaf, Anton Vonk Bogaard, Harm J. Pulm Circ Research Letter Hyperventilation is common in pulmonary arterial hypertension and may be related to autonomic imbalance. Patients underwent exercise testing and hyperoxic breathing before and after bisoprolol treatment. We found that neither beta blocker treatment nor hyperoxic breathing in patients reduced hyperventilation at rest and during exercise, although it reduced heart rate. SAGE Publications 2021-12-13 /pmc/articles/PMC8671678/ /pubmed/34925761 http://dx.doi.org/10.1177/20458940211057890 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Creative Commons CC BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Letter
Peters, Eva L.
van Campen, Jasmijn S.J.A
Groepenhoff, Herman
de Man, Frances S.
Noordegraaf, Anton Vonk
Bogaard, Harm J.
Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients
title Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients
title_full Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients
title_fullStr Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients
title_full_unstemmed Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients
title_short Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients
title_sort bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671678/
https://www.ncbi.nlm.nih.gov/pubmed/34925761
http://dx.doi.org/10.1177/20458940211057890
work_keys_str_mv AT peterseval bisoprololandorhyperoxicbreathingdonotreducehyperventilationinpulmonaryarterialhypertensionpatients
AT vancampenjasmijnsja bisoprololandorhyperoxicbreathingdonotreducehyperventilationinpulmonaryarterialhypertensionpatients
AT groepenhoffherman bisoprololandorhyperoxicbreathingdonotreducehyperventilationinpulmonaryarterialhypertensionpatients
AT demanfrancess bisoprololandorhyperoxicbreathingdonotreducehyperventilationinpulmonaryarterialhypertensionpatients
AT noordegraafantonvonk bisoprololandorhyperoxicbreathingdonotreducehyperventilationinpulmonaryarterialhypertensionpatients
AT bogaardharmj bisoprololandorhyperoxicbreathingdonotreducehyperventilationinpulmonaryarterialhypertensionpatients

Ejemplares similares